Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $10.721 million which beat the analyst consensus estimate of $10.585 million by 1.28 percent. This is a 30.51 percent increase over sales of $8.215 million the same period last year.
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $10.721 million which beat the analyst consensus estimate of $10.585 million by 1.28 percent. This is a 30.51 percent increase over sales of $8.215 million the same period last year.
Comments